Novo Seeks To Halt Caraco Launch Of Generic Prandin
By Morgan Bettex ( February 26, 2009, 12:00 AM EST) -- Novo Nordisk Inc. has asked a federal court to stop Caraco Pharmaceutical Laboratories Ltd. and its majority shareholder Sun Pharmaceutical Industries Ltd. from launching a generic version of Novo's diabetic drug Prandin before Novo has a chance to present its patent infringement case at trial....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.